USPTO serial 79258227
TISSIUM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 6, 2020
- Examiner
- CROWDER-SCHAEFER, ANDREW W
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with TISSIUM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*
Plus Government fees of $1,700
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Dmitriy O. Makarov
Dmitriy O. Makarov IpHorgan Ltd.195 Arlington Heights Rd, Suite 125Buffalo Grove, IL 60089-1768UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and pharmaceutical veterinary products for the treatment of cardio-vascular diseases, digestive disorders, pulmo-thoracic diseases, neurology diseases, orthopaedic disorders and for tissue reconstruction in the nature of biological tissue grafts; chemical preparations for medical, pharmaceutical, and veterinary use, namely, for the treatment of cardio-vascular diseases, digestive disorders, pulmo-thoracic diseases, neurology diseases, orthopaedic disorders, dental applications, drug delivery agents in the form of biodegradable films that facilitate the delivery of pharmaceutical preparations and for tissue reconstruction in the nature of biological tissue grafts; chemical preparations for medical, pharmaceutical, and veterinary purpose, namely, for the treatment of cardio-vascular diseases, digestive disorders, pulmo-thoracic diseases, neurology diseases, orthopaedic disorders, dental applications, drug delivery agents in the form of biodegradable films that facilitate the delivery of pharmaceutical preparations and for tissue reconstruction in the nature of biological tissue grafts; pre-polymers and polymers for pharmaceutical, medical, dental, and veterinary uses, in the nature of adhesives, namely, medical adhesives for binding internal tissue, medical adhesive tape, medical adhesives for binding wounds, medical adhesives in the form of polymerized liquid for medical and surgical purposes to attach devices to tissue, medical adhesive in the form of polymerized liquid for medical purposes to attach devices together, drug delivery agents in the form of medical dissolvable films that facilitate the delivery of pharmaceutical preparations; sealants being medical adhesives in the form of polymerized liquid, namely, medical sealants to avoid the leakage of biological fluids and air, medical sealants to repair fissures and augment sutures and staples; filler in the nature of medical adhesives for binding internal tissues and surgical glue, namely, urogenital fillers and gastrointestinal fillers, fillers to fill hard and soft tissue defects, fillers to augment tissue and create volume, namely, injectable dermal filler and breast implants fillers, all consisting of biological materials; barriers, namely, pharmaceutical preparations for skin wounds in the nature of anti-adhesion barrier to coat tissue, protective barrier layer on skin, barrier to distribute forces across tissues, barrier to prevent tissue expansion or restrict volume, barrier to prevent infections, barrier to prevent tissue ingrowth and cell migration; and resins, namely, resins to produce resin cement through molding, extrusion or 3D printing; adhesive products for medical, surgical, dental, cosmetic, veterinary and pharmaceutical uses, namely, adhesives to bind, protect, fill and reconstruct internal and external tissue, namely, medical adhesives for binding internal tissue, medical adhesives tape, medical adhesives for binding wounds; chemical and biological preparations for medical, surgical, dental, veterinary and pharmaceutical uses, namely, for the treatment of cardio-vascular diseases, digestive disorders, pulmo-thoracic diseases, neurology diseases, orthopedic disorders, dental applications and as drug delivery agents in the form of biodegradable films that facilitate the delivery of pharmaceutical preparations; products for medical use, namely, chirurgical medical adhesives for binding internal tissue, medical adhesive tape, medical adhesives for binding wounds, medical adhesives in the form of polymerized liquid for medical and surgical purposes to attach devices to tissue, medical adhesive in the form of polymerized liquid for medical purposes to attach devices together, drug delivery agents in the form of medical that facilitate the delivery of pharmaceutical preparations and diagnostic preparations for medical use; cultures of microorganisms for medical or veterinary use; enzyme preparations for medical use | ACTIVE | — |
| 010 | Medical, surgical, cosmetic, veterinary and dental apparatus, instruments and devices, namely, disposable syringes, as well as open surgery, minimally invasive, interventional, endoscopic, laparoscopic surgical devices and instruments and surgical robots for use in cardiac, vascular, thoracic, gastrointestinal, neuro, urology, orthopedic, maxilo-facial, plastic and ophthalmological surgeries; suture material; prostheses, namely, medical prostheses for tissue repair and reconstruction, dental prostheses, bone prostheses, biodegradable bone fixation implants; implants consisting of artificial materials; artificial implants; syringes for medical, surgical or dental use and applicators being a component part of syringes for medical, surgical and dental applications, sold as a unit; surgical lamps; lamps for medical use, namely, polymerization light sources for medical applications in the nature of light emitting diode (LED) apparatus for lighting, incorporated into medical instruments and ultraviolet lamps for medical purposes; heating lamps for medical applications; dental care lamps, namely, polymerization light sources for dental applications in the nature of light emitting diode (LED) apparatus for lighting, incorporated into medical instruments and ultraviolet lamps for medical purposes | ACTIVE | — |
| 042 | Biochemical and biological research services; science and technology research and development services, namely, chemical and medical chemistry research; pharmaceutical research; chemical analysis; bacteriological research; medical research; design and development of computer software and databases in the field of medicine, clinical studies; quality control services for products and preparations for medical purposes; research and development services for pharmaceutical preparations; pharmaceutical product evaluation, namely, screening service for active ingredients in the medical and pharmaceutical field; research and development services in the field of health in the nature of pharmaceuticals and biotechnology; online data collection of medical, pharmaceutical and health data using proprietary software to collect service data; online data collection with information on prevention, therapy and disease monitoring using proprietary software to collect service data; collection of data containing scientific and economic information using proprietary software to collect service data | ACTIVE | — |
| 044 | Medical services; veterinary services; hygienic and beauty care for human beings and animals, consultation in pharmacy and health, namely, medical and pharmaceutical consultation; awareness-raising and information programs in the field of health, namely, providing a website featuring information about health, namely, vascular awareness and information about screening and treatment | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by GECKO BIOMEDICAL
- Other trademarks owned by TISSIUM
- Other trademarks owned by TISSIUM
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named TISSIUM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 6, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 13, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 25, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 25, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 6, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 6, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 2, 2020 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 31, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 21, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 21, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 15, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 15, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 1, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 12, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 29, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 29, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 29, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Dec 20, 2019 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 20, 2019 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 20, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 6, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 6, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 5, 2019 | ALIE | ASSIGNED TO LIE | — |
| Nov 26, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 28, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 11, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 11, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 29, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 28, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 21, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| May 14, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 10, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 9, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |